A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies

Completed · Phase 3

Conditions studied: HIV Infections, Pregnancy

In brief

The purpose of this study is to see if giving the anti-HIV drug nevirapine (NVP) to HIV-positive pregnant women and their babies can help reduce the chance that a mother will give HIV to her baby during delivery. This study will also test the safety of the drug and see how well it is tolerated by the mother and her baby. Previous studies suggest that NVP is a promising medication for blocking HIV transmission from HIV-positive mothers to their babies.

Key facts

Study ID
NCT00000869
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
2009
Expected to finish
2001-05-01
Last updated by the study team
2021-10-28

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.